Reyon Pharmaceutical Co. Ltd. | Mutual Funds
Mutual Funds that own Reyon Pharmaceutical Co. Ltd.
DFA Emerging Markets Small Cap Series
56,716
0.34%
0
0.02%
01/31/2018
DFA Emerging Markets Core Equity Portfolio
30,379
0.18%
0
0%
04/30/2018
iShares III Plc - MSCI Emerging Markets Small Cap
4,125
0.03%
0
0.02%
09/05/2018
CREF Stock Account
3,533
0.02%
0
0%
03/31/2018
2,936
0.02%
1,507
0.03%
04/30/2018
Dimensional Funds ICVC - Emerging Markets Core Equity Fund
1,742
0.01%
0
0%
12/31/2017
SSgA SPDR ETFs Europe I Plc - MSCI ACWI IMI UCITS ETF
1,094
0.01%
0
0.02%
09/06/2018
John Hancock II - Emerging Markets Fund
941
0.01%
0
0%
04/30/2018
DFA Emerging Markets Social Core Equity Portfolio
936
0.01%
0
0%
04/30/2018
iShares II Plc - MSCI AC Far East (ex-Japan) Small Cap
688
0%
0
0.02%
09/05/2018
| Address |
8th Floor, Cosmo Tower
Seoul SL 06176
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://reyonpharm.co.kr |
| Updated |
07/08/2019 |
| REYON PHARMACEUTICAL Co., Ltd. engages in the manufacture and sale of pharmaceuticla products. Its products include medicines for antibiotic, circulatory system, anti-inflammation, contrast media, and others. The Company was founded on November 25, 1984 and is headquartered in Seoul, South Korea. |
